Tasigna Lawsuit Lawyer

Our law firm is currently handling lawsuits on behalf of individuals who have been injured after being treated with Tasigna. Lawsuits against the manufacturers of Tasigna claim that the oral chemotherapy regimen can cause serious side effects including death, as indicated in the the Food and Drug Administration (FDA) Adverse Events Reporting Systems Public Dashboard.

What Do We Know about Tasigna Lawsuits?

Tasigna is an oral chemotherapy used for the treatment of a blood cancer known as Philadelphia chromosome-positive chronic myeloid leukemia or PH+ CML. Philadelphia chromosomes are abnormal chromosome in the bone marrow. Tasigna is administered to improve blood counts and reject the Philadelphia chromosome.

Tasigna presents an increased risk of blocked arteries, irregular heart rhythms, and death. Several studies have shown that patients taking Tasigna developed atherosclerosis that rapidly progressed into serious disease. Patients have initiated lawsuits against Novartis, the manufacturer of Tasigna, for failing to provide adequate warnings about the risk of atherosclerosis, which causes long-term obstruction of the arteries.

Tasigna Injuries

The main complication of Tasigna is atherosclerosis. While atherosclerosis is generally a progressive condition, patients taking Tasigna may experience severe and rapid deterioration of the arteries. Tasigna can cause other serious conditions including heart attack, stroke, blood clots, peripheral artery disease, myocardial ischemia, carotid artery stenosis, obstruction in the blood vessels, and death.

How Our Law Firm Can Help You

The Lake Law Firm was founded by Edward J. Lake, Esq., a personal injury lawyer for over 25 years. Our dedicated team of attorneys is committed to seeking justice on behalf of those who have suffered injury or death due to the negligence of others. Our experienced attorneys handle many different types of pharmaceutical drugs, medical devices, and other defective products. The lawyers in our firm have helped collect millions of dollars for their clients. The Lake Law Firm will advocate for you and your rights. Please contact us for a free confidential case evaluation at (888) 274-0139 or submit an inquiry on this page.

Tasigna and Studies Linking Tasigna to Cardiovascular Disease

Tasigna was approved by the FDA in 2007 with a black box warning that addressed only the minor side effects of the medication.  Following Tasigna’s approval by the FDA, more than a dozen studies have shown that Tasigna may cause atherosclerosis and other cardiovascular issues that increase the risk of stroke and death.

In a 2011 study, three of 24 patients developed progressive peripheral arterial occlusive disease (PAOD) while being treated with Tasigna and required angioplasty and multiple surgeries. PAOD was not detected in these patients prior to treatment with Tasigna.

In 2015, a report in the Journal of Clinical Oncology discussed cardiovascular events associated with Tasigna and concerns about the long-term use of Tasigna.

A warning regarding atherosclerosis was added to Tasigna’s product label, but the FDA did not officially release a warning concerning these complications.